In a wide-ranging interview, Xavier Becerra, President Biden’s health secretary, defended his tenure and hinted that he might run for governor of California.

As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, Medicare director Meena Seshamani, and FDA Center for Drug Evaluation and Research director Patrizia Cavazzoni have retired or intend to retire prior to Trump's inauguration on Jan. 20.

Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country healthier and stronger."

Secretary Xavier Becerra spoke to The Washington Post about falling trust in his department since the coronavirus pandemic.

Xavier Becerra, who has led the Department of Health and Human Services, says federal agencies are outmatched in a world of “instantaneous information and disinformation.”

Millions of people were eager to line up for jabs of the newly-released COVID-19 vaccines. That's the scene the nation's top health official, Xavier Becerra, wants Americans to remember as he readies to leave the office, possibly to Robert F. Kennedy Jr ...

Sen. Ted Cruz supports Pam Bondi's confirmation as attorney general, calling her Trump's most crucial nominee and praising her strong hearing performance.

U.S. Health and Human Services Secretary Xavier Becerra has indicated the government's intention to negotiate more affordable prices for 15 expensive Medicare drugs by 2027. Becerra emphasizes the effectiveness of the medications but insists their costs need reduction,

U.S. Health and Human Services Secretary Xavier Becerra said on Friday the government will try to negotiate better prices for the 15 drugs targeted for Medicare price negotiations for 2027 because they are too expensive.

U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top priority for the federal government.

US health officials announced on Friday that they were awarding US$590 million to Moderna to develop mRNA vaccines against influenza, including advancing